Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Apr 05, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000005.pdf 0001968202-23-000005.xls
Apr 05, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000007.pdf 0001968202-23-000007.xls
Mar 29, 2023	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-23-038299.pdf 0001104659-23-038299.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 29, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000004.pdf 0001968202-23-000004.xls
Mar 27, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000060.pdf 0001883850-23-000060.xls
Mar 27, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000061.pdf 0001883850-23-000061.xls
Mar 27, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000063.pdf 0001883850-23-000063.xls
Mar 27, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000062.pdf 0001883850-23-000062.xls
Mar 27, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000064.pdf 0001883850-23-000064.xls
Mar 14, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000002.pdf 0001968202-23-000002.xls

Data provided by Kaleidoscope.

Investors & Media